PP01.20: Integrating Clinicopathologic and Genomic Features to Identify Patients at Risk of Earlier Progression to First-Line Osimertinib in EGFR-Mutant NSCLC
Federica Pecci, Mark Jeng, Alessandro Di Federico, M. Peroni et autres
us, it, gb, fr, ca (code pays fourni par la source)